Although he sometimes contends that science research is only a hobby, the founder of Microsoft (Seattle, WA) is fascinated with biotech. And he has decided to spend some of the wealth he accumulated through his company to finance research for neglected diseases—an initiative that has inspired ...
1. The “What” of APOE transgenic AD mouse models: the development of AD pathology and the effect of universal biological variables Alzheimer’s Disease (AD) is a complex, uniquely human condition that has eluded understanding and effective treatment for over a century. Nevertheless, dozens of ...
(WHO).W 5、HO is not responsible for the content or accuracy of this translation.The original English edition shall be the binding and authentic edition”.Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of the World ...
and also ulcers. The most commonly prescribed medications to treat what is known as gastro-oesphageal reflux disease, are "proton pump inhibitors".
Smith made his breakthrough in 1985 with the development of phage display, a method in which a bacteriophage (a virus that infects bacteria) is used to create new proteins. Winter later used this method for the directed evolution of antibodies that led to new pharmaceuticals, the first of wh...
Dose and treatment duration guidance, for CSFs, varies according to the agent used, the nature of the malignancy and patient demographics. However, G-CSF therapy is often initiated between 24 and 72 h after SACT administration and continued according to the corresponding chemotherapy protocol or ...